O
33
-4
PX
66
4
TDC
47
-39
OI
34
6
STZ
47
-3
CAT
59
4
NUE
51
3
XOM
42
2
TRV
48
2
APH
65
4
AVB
54
9
HIG
54
2
GLW
48
2
UPS
28
3
PHM
60
6
DFS
60
4
PNW
66
3
NVDA
55
4
LMT
29
2
CHRW
53
3
O
33
-4
PX
66
4
TDC
47
-39
OI
34
6
STZ
47
-3
CAT
59
4
NUE
51
3
XOM
42
2
TRV
48
2
APH
65
4
AVB
54
9
HIG
54
2
GLW
48
2
UPS
28
3
PHM
60
6
DFS
60
4
PNW
66
3
NVDA
55
4
LMT
29
2
CHRW
53
3
Financhill
Back

Entrada Therapeutics Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
64

TRDA
Entrada Therapeutics

Last Price:
19.00
Seasonality Move:
-34.31%
Sell
31

SRPT
Sarepta Therapeutics

Last Price:
125.81
Seasonality Move:
11.13%
Buy
64
Entrada Therapeutics (TRDA) is a Buy

Is Entrada Therapeutics a Buy, Sell or Hold?

  • The current Entrada Therapeutics [TRDA] share price is $18.62. The Score for TRDA is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • TRDA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $125.01. The Score for SRPT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TRDA Stock Price Chart

What is Entrada Therapeutics's stock price today?

  • The Entrada Therapeutics share price today is $18.62
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $125.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

TRDA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.46 Buy
Relative Strength Index (14 RSI): 68.97 Buy
Chaikin Money Flow: 153692 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.42 - 17.68) Buy
Bollinger Bands (100): (14.77 - 17.19) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.16 Sell
Relative Strength Index (14 RSI): 46.43 Sell
Chaikin Money Flow: 728345 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (120.8 - 128.94) Buy
Bollinger Bands (100): (123.42 - 147.2) Sell

TRDA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.5 Buy
20-day SMA: 17.19 Buy
50-day SMA: 16.25 Buy
200-day SMA: 14.96 Buy
8-day EMA: 17.65 Buy
20-day EMA: 17.18 Buy
50-day EMA: 16.55 Buy
200-day EMA: 15.47 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 127.08 Sell
20-day SMA: 126 Sell
50-day SMA: 127.18 Sell
200-day SMA: 130.57 Sell
8-day EMA: 125.96 Sell
20-day EMA: 126.26 Sell
50-day EMA: 128.02 Sell
200-day EMA: 127.82 Sell

Entrada Therapeutics Earnings Growth & TRDA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $3.79 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.72 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.19 per share, and an increase next year of $8.77 per share.

Entrada Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):